期刊文献+

食管鳞状细胞癌组织telom erase及PCNA的表达意义 被引量:1

Expression of telomerase and PCNA protein in esophageal squamous cell carcinoma tissue and its significance
暂未订购
导出
摘要 目的:探讨telom erase与PCNA在中晚期食管癌不同大体病理类型的表达.方法:应用免疫组织化学方法观察不同大体病理类型的中晚期食管癌共126例,其中蕈伞型30例,缩窄型28例,溃疡型32例,髓质型36例.并用SPSS10.0软件分析结果.结果:中晚食管鳞状细胞癌的telom erase,PC-NA的阳性表达率分别是:蕈伞型60.0%与83.3%;缩窄型75.0%与78.5%;溃疡型75.0%与15.6%;髓质型44.4%与77.8%.2χ检验telom erase:2χ=378.829,P<0.005.PCNA:2χ=357.656,P<0.005,各组差异显著.结论:telom erase,PC-NA在不同的中晚期食管癌的大体分型之间表达不同,同时进行telom erase与PCNA免疫组化检测对于评估食管癌的预后会更有意义. AIM: To study the expression of telomerase and PCNA protein in four different pathological types of advanced esophageal cell cancer. METHODS: One hundred and twenty-six cases with esophageal cancer of different pathological types were included in study by immunohisto- chemistry and the results were analyzed by SPSS 10.0. RESULTS: The positive rates of telomerase expression and PCNA were 60.0% (18/30) and 83.3% (25/30) in fungating type, 75.0% (21/28) and 78.5% (22/28) in constrictive type, 75.0% (24/32) and 15.6% (5/32) in ulcerative type and 44.4% (16/36) and PCNA 77.8% (28/36) in medullary type. Chi-square test was performed (telomerase ;x^2=378. 829, P 〈0. 005 and PCNA ;x^2=357. 656, P 〈 0.005). CONCLUSION: The expression of human telomerase and PCNA gene was different in advanced esophageal cell cancer of different pathological types. Simultaneous immunohistochemistry examination of both telomerase and PCNA is of significance for the prognosis of esophageal cancers.
出处 《第四军医大学学报》 北大核心 2005年第19期1800-1801,共2页 Journal of the Fourth Military Medical University
关键词 食管癌 类型 端粒酶 增殖细胞核抗原 免疫组化 esophageal neoplasms type telomerase PCNA immunohistochemistry
  • 相关文献

参考文献8

二级参考文献10

  • 1[3]Gupta D, Shidham V, Holden J, et al. Value of topoisomerase II alpha, MIB-1, p53, E-cadherin, retinoblastoma gene protein product, and HER-2/neu immunohistochemical expression for the prediction of biologic behavior in adrenocortical neoplasms [J]. Appl Immunohistochem Mol Morphol, 2001;9(3):215-221.
  • 2[4]Eguchi T, Tokuyama A, Tanaka Y, et al. Hypoglycemia associated with the production of insulin-like growth factor II in adrenocortical carcinoma [J]. Intern Med, 2001;40(8):759-763.
  • 3[5]Gicquel C, Bertagna X, Gaston V, et al. Molecular markers and long-term recurrences in a large cohort of patients with sporadic adrenocortical tumors [J]. Cancer Res, 2001;61(18):6762-6767.
  • 4[6]Salmenkivi K, Haglund C, Ristimaki A, et al. Increased expression of cyclooxygenase-2 in malignant pheochromocytomas [J]. J Clin Endocrinol Metab, 2001;86(11):5615-5619.
  • 5Pao C C,J Clin Oncol,1997年,15卷,5期,1932页
  • 6Rhyu M S,J Natl Cancer Inst,1995年,87卷,12期,844页
  • 7Kim N W,Science,1994年,266卷,23期,2011页
  • 8王强,中国实验诊断学杂志,1999年,3卷,6期,261页
  • 9王强,吴清明,王小虎,徐少勇,谢国建.端粒酶对良恶性腹水的鉴别诊断价值[J].中国实验诊断学,1999,3(6):261-262. 被引量:14
  • 10王强,吴清明,姜东升,李胜保.细针穿刺细胞端粒酶定量检测的应用价值[J].实用癌症杂志,2000,15(6):615-616. 被引量:5

共引文献13

同被引文献19

引证文献1

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部